Insight Molecular Diagnostics Inc.

IMDX · XNAS

CIK 1642380fmd_1VZEPPC1HQZTPN4VS4TR5DX5NGManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2014 to Jun 30, 2026, 47 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.